SHARE:   Share to Facebook Share to Twitter Share to Linked In Share via Email  

Back To Search Results

C193 - Peripheral Neuropathy I: Anatomical Basis and Acquired Demyelinating Neuropathies

Event Time: Thursday April 27, 2017 7:00 am to 9:00 am
Topic(s): Neuromuscular and Clinical Neurophysiology (EMG)
Director(s): Michael Shy MD
Description: Peripheral neuropathies (PN) ultimately affect almost 10 percent of the population. New diagnostic and management options make rational therapies for PN increasingly possible. However, the high cost of certain diagnostic tests and therapies, along with the complexities involved in choosing which tests and treatments to initiate, complicate the management of patients with PN. The Peripheral Nerve Society (PNS) and AAN Neuromuscular Section will present three two-hour courses devoted to the diagnosis and management of these disorders. Faculty will provide an overview of the peripheral nervous system, including a pathological overview of PN, and review the diagnosis and management of acquired immune-based ceuropathies, including Guillain Barre syndrome and CIDP. This program complements C204: Peripheral Neuropathy II: Diabetic and Inherited Neuropathies and C217: Peripheral Neuropathy III: Genetic Testing and Next Generation Sequencing, but covers independent topics.
Completion Message: Participants should be able to understand the anatomical basis and pathological consequences of peripheral neuropathies, distinguish between acquired and inherited peripheral neuropathies, and use a rational, evidence-based approach to treat acquired immunologically based peripheral neuropathies.
CME Credits: 2
Core Competencies: Medical Knowledge, Patient Care

Program Speakers - Tentative

Start/End Time Title Faculty
7:00 AM - 7:45 AM Peripheral Neuropathy—Overview of Anatomy and Pathology Steven Scherer MD 
7:45 AM - 8:30 AM Diagnosis and Treatment of Acquired Demyelinating Neuropathies Richard A. Lewis MD, FAAN 
8:30 AM - 9:00 AM Questions and Answers/Case Presentations Richard A. Lewis MD, FAAN, Steven Scherer MD 

Disclosures

Speaker Disclosure
Richard A. Lewis, MD, FAAN Dr. Lewis has received personal compensation for consulting, serving on a scientific advisory board, speaking, or other activities with CSL Behring; Axelacare; Pharnext; Biotest; Kedrion; Nufactor; Optioncare; Grifols. Dr. Lewis has received research support from Neutralis; Cytokinetics.

Steven Scherer, MD Dr. Scherer has received personal compensation for consulting, serving on a scientific advisory board, speaking, or other activities with Disarm Pharmaceutical.

Register Now

Related Courses

Sunday April 22, 2018

7:00 AM-9:00 AM
C31 Peripheral Neuropathy I: Anatomical Basis and Acquired Demyelinating Neuropathies Michael Shy MD
9:15 AM-12:00 PM
PL2 Presidential Plenary Session
1:00 PM-3:00 PM
C41 Peripheral Neuropathy II: Diabetic and Inherited Neuropathies Michael Shy MD
1:00 PM-5:30 PM
C49 Neuromuscular Ultrasound Skills Workshop (Registration Required) Craig Zaidman MD
3:30 PM-5:30 PM
C56 Peripheral Neuropathy III: Genetic Testing and Next Generation Sequencing Michael Shy MD

Tuesday April 24, 2018

12:00 PM-12:45 PM
Treatment of Neuropathy Symptoms Without Medication Janice Wiesman MD, FAAN
1:00 PM-3:00 PM
S22 Neuromuscular and Clinical Neurophysiology (EMG) Platform Session
1:00 PM-5:30 PM
C119 EMG Skills Workshop: Basic (Registration Required) Ezgi Tiryaki MD, FAAN
3:30 PM-5:30 PM
S25 Neuromuscular and Clinical Neurophysiology (EMG) Platform Session

MEMBER LOG IN

Forgot Password?